SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-195944
Filing Date
2024-08-07
Accepted
2024-08-07 16:50:12
Documents
18
Effectiveness Date
2024-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 d881385ds8.htm S-8 32580
2 EX-5.1 d881385dex51.htm EX-5.1 6419
3 EX-23.2 d881385dex232.htm EX-23.2 2766
4 EX-FILING FEES d881385dexfilingfees.htm   iXBRL EX-FILING FEES 24577
5 GRAPHIC g881385dsp7.jpg GRAPHIC 7667
6 GRAPHIC g881385g59w45.jpg GRAPHIC 11412
7 GRAPHIC g881385g98d60.jpg GRAPHIC 4735
  Complete submission text file 0001193125-24-195944.txt   232389

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT d881385dexfilingfees_htm.xml XML 6954
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281334 | Film No.: 241184615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)